| Delaware                                                                                    | 04-2869857                                          |
|---------------------------------------------------------------------------------------------|-----------------------------------------------------|
| (State                or Other Jurisdictionof                Incorporation or Organization) | (I.R.S.                employer identification No.) |

| 9033                  Red Branch Rd., Columbia, MD      | 21045                     |
|---------------------------------------------------------|---------------------------|
| (Address                of Principal Executive Offices) | (Zip                Code) |
|                                                    |                      |

| (443)                  367-5500                                       |
|-----------------------------------------------------------------------|
| (Issuer’s                telephone number, Including Area Code) |

----

----

|                     | Page                                                                                                                                                         |
|--------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PART                III. |                                                                                                                                                         |
| Item                9.   | Directors,                Executive Officers, Promoters and Control Persons; Compliance with                Section                16(a) of the Exchange Act | 6 |
| Item                10.  | Executive                Compensation                                                                                                                        | 9 |
| Item                11.  | Security                Ownership of Certain Beneficial Owners and Management and Related                Stockholder Meeting                                 | 10 |
| Item                12.  | Certain                Relationships and Related Transactions                                                                                                | 11 |
| Item                13.  | Exhibits                                                                                                                                                     | 11 |
| Item                14.  | Principal                Accountant Fees and Services                                                                                                        | 11 |
| EX-31.1                  |                                                                                                                                                         |   |
| EX-31.2                  |                                                                                                                                                         |   |
| EX-32.1                  |                                                                                                                                                         |   |
| EX-32.2                  |                                                                                                                                                         |   |
|                     |                                                                                                                                                         |   |

----

----

| Item                9. | Directors,                Executive Officers, Promoters and Control Persons; Compliance With                Section                16(a) of the Exchange Act. |
|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|

| William                P. HalesDirector                since 1999Term                expires 2008Age:   45  | William                P. Hales has been a Director of Hemagen and its President since October                1,                1999 and its Chairman of the Board of Directors since February                2004.  Mr. Hales has served as Hemagen’s CEO since                2002.  From 1997 to January 2001, Mr. Hales was an Investment                Banker and Advisor with Jesup & Lamont Securities Corporation, an                investment banking and brokerage firm.  Prior to that, Mr. Hales                spent six years in public accounting with Ernst & Young and Coopers                & Lybrand advising clients on both audit and management consulting                engagements.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|----------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Dr.                Alan S. CohenDirector                since 1993Term                expires 2009Age:   81 | Dr.                Cohen has served as a Director of Hemagen since its inception. Dr.                Cohen                has been a Professor of Medicine at Boston University School of Medicine                since 1968 and a Professor of Pharmacology since 1974.  He is                currently Distinguished Professor of Medicine(E).  Dr. Cohen is                Editor-in-Chief of  AMYLOID. The Journal                of                Protein Folding Disorders.  Dr. Cohen served as the                Director of the Arthritis Center of Boston University from 1976 to                1994.  From 1973 to 1992, Dr. Cohen served as Chief of Medicine                of Boston City Hospital.  Dr. Cohen is a past president of the                American College of Rheumatology.  Dr. Cohen received his                Bachelor of Arts degree from Harvard College and his M.D. degree                from the                Boston University School of Medicine.                                                                                                                                                                                                                                                                                                                                                              |
| Richard                W. EdwardsDirector                since 2003Term                expires 2009Age:                48  | Mr.                Edwards has served as the Chief Financial Officer of Trust Atlantic                Financial Corporation since 2006.  Prior to joining Trust                Atlantic, he served as Chief Financial Officer of Square 1 Financial                Inc.,                a privately held bank holding company, from August 2005 to                2006.  Prior to joining Square 1 Financial, he served as Chief                Financial Officer of Capital Bank Corporation, a publicly traded                bank                holding company, from April 2004 to August 2005.  He served as                Senior Vice President and the Chief Accounting Officer of National                Commerce Financial Corporation, a NYSE traded bank holding company,                from                July 2002 to April 2004.  From January 2001 to July 2002, Mr.                Edwards was the Chief Financial Officer of New South Bancshares,                Inc. He                spent eight years in various senior financial roles with Bank of                America                prior to January 2001 and eight years in public accounting with Ernst                & Young prior to that.  Mr. Edwards earned a B.S. degree in                accounting from the University of Illinois and is a member of the                AICPA. |
| Edward                T. LutzDirector                since 2004Term                expires 2007Age:   61    | Mr.                Lutz has been the President & CEO of Lutz Advisors, Inc. since                2001.  Prior to that Mr. Lutz served Tucker Anthony Sutro                Capital Markets within the Investment Banking Group focusing on the                bank                and thrift industry.  He has over thirty-five years experience                in bank regulation, mergers and acquisitions of troubled financial                institutions, strategic planning and structuring financial                transactions.  Over the last 13 years he has specialized in                investment banking and consulting to bank and thrift                institutions.  Mr. Lutz is a member of the board of directors of                Union State Bank (NYSE) and U.S.B Holding Co., Inc. (NYSE).  Mr.                Lutz is the Chairman of the Audit Committee of Union State                Bank.  Mr. Lutz earned his B.A. in Economics from Hofstra                University and his M.B.A in Finance from American University.                                                                                                                                                                                                                                                                                                          |

| Name                                 | Age | Position                                                                             |
|--------------------------------------|-----|--------------------------------------------------------------------------------------|
| William                P. Hales      | 45  | Chairman                of the Board, President and Chief Executive Officer          |
| Catherine                M. Davidson | 42  | Controller,                Principal Financial and Accounting                Officer |

----

| Name                  and Principal Position(a) | Year(b)    |   | Salary($)(c) |    |   | Bonus($)(d) |   |   | Stock                  Awards($)(e) |   |   | Option                  Awards($)(f) |   |   | Non-Equity                  Incentive Plan Compensation($)(g) |   |   | Nonqualified                  Deferred Compensation Earnings($)(h) |   |   | All                  Other Compensation Compensation($)(i)(1) |   |   | Total($)(j) |   |
|-------------------------------------------------|------------|--------|--------------|---------|--------|-------------|--------|--------|-------------------------------------|--------|--------|--------------------------------------|--------|--------|---------------------------------------------------------------|--------|--------|--------------------------------------------------------------------|--------|--------|---------------------------------------------------------------|--------|--------|-------------|--------|
| William                P. Hales                 | 2007       |   |         | 176,250 |   |        |   |   |                                |   |   |                                 |   |   |                                                          |   |   |                                                               |   |   |                                                          |   | 41,124 |  (1)   |   |   | 217,374 |   |
|                                            | 2006       |   |         | 176,250 |   |        |   |   |                                |   |   |                                 | $      | 42,157 |                                                          |   |   |                                                               |   |   |                                                          |   |   |        |   | 41,184 |  (2) |   |   | 259,591 |   |
|                                            |       |   |         |    |   |        |   |   |                                |   |   |                                 |   |   |                                                          |   |   |                                                               |   |   |                                                          |   |   |        |   |   |   |   |   |   |   |
|  Catherine              M. Davidson        |  2007 |   |         | 50,570  | (3)    |        |   | --     |                                |   |   | --                                   |   |   | $                                                             | 5,218  |   |                                                               |   | --     |                                                          |   |   | --          |   |   |   | -- |   |   |   | 55,788 |   |
|                                            |       |   |         |    |   |        |   |   |                                |   |   |                                 |   |   |                                                          |   |   |                                                               |   |   |                                                          |   |   |        |   |   |   |   |   |   |   |   |   |

|   | (1) | Represents                $26,760 in provision of use of a company apartment, and $8,364 for                a                leased car and $6,000 estimated for the Company’s contributions in the                Employee Stock Ownership Plan. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | (2) | Represents              $26,760 in provision of use of a company apartment, and $8,364 for              a              leased car and $6,060 for the Company's contributions in the Employee              Stock Ownership Plan.                         |
|   | (3) | Represents              salary paid for fiscal 2007.  Mrs. Davidson started with the Company              in April 2007.  Mrs. Davidson's annual salary is              $115,000.                                                        |

----

|                                     |   | Option                  Awards                                                          |      | Stock                  Awards |                                                                                                       |
|------------------------------------------|--------|-----------------------------------------------------------------------------------------|-----------|-------------------------------|------------------------------------------------------------------------------------------------------------|
| Name(a)                                  |   | Number                  of Securities Underlying Unexercised Options (#) Exercisable(b) |      |                          | Number                  of Securities Underlying Unexercised Options (#)                  Unexercisable(c) |   |   | Equity                  Incentive Plan Awards Number of Securities Underlying Unexercised                  Unearned                  Options (#)(d) |   |   | Option                  Exercise Price($)(e) |   | Option                  Expiration Date(f) |   | Number                  of Shares or Units of Stock That Have Not Vested (#)(g) |   |   | Market                  Value of Shares or Units of Stock That Have Not Vested ($)(h) |   |   | Equity                  Incentive Plan Awards: Number of Unearned Shares, Units or Other                  Rights                  That Have Not Vested (#)(i) |   |   | Equity                  Incentive Plan Awards: Market or Payout Value of Unearned Shares,                  Units or                  Other Rights That Have Not Vested ($)(j) |   |
| William                Hales             |   |                                                                                    | 1,630,148 |                          |                                                                                                       |   | -- |   |   |   | -- |   |   |   | 1.36 |   |  9/30/2009 |   |   | -- |   |   |   | -- |   |   |   | -- |   |   |   | -- |   |
|                                     |   |                                                                                    | 250,000   |                          |                                                                                                       |   | -- |   |   |   | -- |   |   |   | .20 |   |  10/25/2015 |   |   | -- |   |   |   | -- |   |   |   | -- |   |   |   | -- |   |
|  Catherine              M. Davidson |   |                                                                                    | --        |                          |                                                                                                       |   | 35,000 |   |   |   | -- |   |   |   | .22 |   |  4/23/2012 |   |   | -- |   |   |   | -- |   |   |   | -- |   |   |   | -- |   |

| Name(a)                                      |   | Fees                  Earned or Paid in Cash($)(b) |   |   | Stock                  Awards($)(c) |   |   | Option                  Awards ($)(d) |   |   | Non-Equity                  Incentive Plan Compensation($)(e) |   |   | Nonqualified                  Deferred Compensation Earnings($)(f) |   |   | All                  Other Compensation($)(g) |   |   | Total($)(h) |   |
|----------------------------------------------|--------|----------------------------------------------------|--------|--------|-------------------------------------|--------|--------|---------------------------------------|--------|--------|---------------------------------------------------------------|--------|--------|--------------------------------------------------------------------|--------|--------|-----------------------------------------------|--------|--------|-------------|--------|
|  Alan              S. Cohen   |   |                                               | 6,000  |   |                                |   | 4,000  |                                  |   |   | --                                                            |   |   |                                                               | --     |   |                                          |   | --     |        |   |   | -- |   |   |   | 10,000 |   |
|                                         |   |                                               |   |   |                                |   |   |                                  |   |   |                                                          |   |   |                                                               |   |   |                                          |   |   |        |   |   |   |   |   |   |   |   |
| Richard              W. Edwards         |   |                                               | 6,000  |   |                                |   | 4,000  |                                  |   |   | --                                                            |   |   |                                                               | --     |   |                                          |   | --     |        |   |   | -- |   |   |   | 10,000 |   |
|                                         |   |                                               |   |   |                                |   |   |                                  |   |   |                                                          |   |   |                                                               |   |   |                                          |   |   |        |   |   |   |   |   |   |   |   |
|  Edward              T. Lutz            |   |                                               | 6,000  |   |                                |   | 4,000  |                                  |   |   | --                                                            |   |   |                                                               | --     |   |                                          |   | --     |        |   |   | -- |   |   |   | 10,000 |   |

| Item                11. | Security                Ownership of Certain Beneficial Owners and Management and Related                Stockholder Matters. |
|-------------------------|-------------------------------------------------------------------------------------------------------------------------------|

| Title                  of Class | Name                  and Address of Beneficial Owner                                                                                                                  |   | Amount                  and NatureOf                  Beneficial Owner |      |   | Percent                  of Class |   |
|---------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|------------------------------------------------------------------------|-----------|--------|-----------------------------------|--------|
| Common                Stock     | William                P. HalesPresident                & CEO, Director9033                Red Branch Rd.Columbia,                MD 21045                    |   |                                                                   | 3,705,198 | (1)    |                              |   | 20.8 | % |
| Common                Stock     | Jonathan                E. Rothschild1061-B                Shary CircleConcord,                CA 94518                                                           |   |                                                                   | 1,133,021 | (2)    |                              |   | 7.4 | % |
| Common                Stock     | Dr.                Alan Cohen Director54                Winston Rd.Newtown,                MA 02459                                                               |   |                                                                   | 301,528   | (3)    |                              |   | 2.0 | % |
| Common                Stock     | Richard                W. EdwardsDirector9316                Teton Pines WayRaleigh,                NC 27617                                                      |   |                                                                   | 122,167   | (4)    |                              |   | 0.8 | % |
| Common                Stock     | Edward                T. LutzDirector6                West Sanders St.Greenlawn,                NY 11740                                                          |   |                                                                   | 96,005    | (5)    |                              |   | 0.6 | % |
| Common              Stock       | Catherine                M. DavidsonPrincipal Financial Officer, Principal                AccountingOfficer and Controller9033 Red Branch RoadColumbia, MD 21045  |   |                                                                   | 0         | (6)    |                              |   | 0 | % |
| Common                Stock     | All                Directors and Executive Officers as a Group                                                                                                         |   |                                                                   | 4,224,898 |   |                              |   | 24.2 | % |

| (1) | Includes                1,880,148 shares issuable upon the exercise of options within 60                days and                senior subordinated secured convertible notes convertible into 691,600                shares of common stock within 60 days. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | Based                on Mr. Rothchild’s most recent ownership report filed with the SEC. |
|-----|------------------------------------------------------------------------------------------------|

| (3) | Includes                35,000 shares issuable upon the exercise of options within 60 days                and                19,159 undistributed shares in Directors 10b5-1                Plan. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (4) | Amounts                include 4,500 shares held jointly with spouse, 3,100 owned by a family                member which Mr. Edwards has joint investment authority and 75,408                shares                held directly, and 19,159 undistributed shares in Director's 10b5-1                Plan.                 Includes options to purchase 20,000 shares exercisable within 60                days. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (5) | Includes                15,000 shares issuable upon the exercise of options within 60 days,                and                19,159 undistributed shares in Director's 10b5-1 Plan                                                                                                                                                                                  |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (6) | Mrs.              Davidson was appointed Controller of Hemagen in April 2007.  Prior to              her appointment, Mrs. Davidson served as CFO of Pepco Building Services,              Inc.  Mrs. Davidson's share ownership includes an unvested option to              purchase 35,000 shares, which is not exercisable within 60              days. |

----

| Exhibit                  No. | Description                  of Exhibit                                                                                                                                                                                                                        | Filing                  Status |
|------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------|
| 3.1                          | Certificate                of Incorporation                                                                                                                                                                                                                    | A                              |
| 3.2                          | Bylaws                                                                                                                                                                                                                                                         | A                              |
| 4.1                          | Specimen                Stock Certificate                                                                                                                                                                                                                      | B                              |
| 4.2                          | Rights                Agreement dated January 27, 1999                                                                                                                                                                                                         | B                              |
| 4.3                          | First                Amendment to the Rights Agreement dated September 30, 1999                                                                                                                                                                                | C                              |
| 10.6*                        | 1992                Stock Option Plan                                                                                                                                                                                                                          | A                              |
| 10.17                        | Description                of the Lease for office space of HDC in Sao Paulo, Brazil                                                                                                                                                                           | P                              |
| 10.25                        | Settlement                Agreement dated September 30, 1999                                                                                                                                                                                                   | D                              |
| 10.29                        | Form                of 8% Senior Subordinated Secured Convertible Note                                                                                                                                                                                         | G                              |
| 10.30                        | Second                Amendment to the Lease between the Company and 9033 Red Branch Road,                L.L.C. dated June 9, 2000                                                                                                                            | C                              |
| 10.32                        | Second                Restructuring Agreement between the Company and Dade Behring, Inc.                dated                November 9, 2000                                                                                                                  | E                              |
| 10.35*                       | 2001                Stock Option Plan                                                                                                                                                                                                                          | F                              |
| 10.40                        | Line                of Credit Financing Agreement between Hemagen Diagnostics, Inc. and                Reagents Applications, Inc. and Bay National Bank dated September                26,                2002                                                | K                              |
| 10.42*                       | Directors                Rule 10(b)5-1 Stock Purchase Plan                                                                                                                                                                                                     | L                              |
| 10.44*                       | Hemagen                Employee Stock Ownership Plan                                                                                                                                                                                                           | M                              |
| 10.45                        | Trust                Agreement for the Hemagen Stock Ownership Plan                                                                                                                                                                                            | M                              |
| 10.50                        | Quota                Purchase and Sale Agreement and Non-Competition Agreement                                                                                                                                                                                 | M                              |
| 10.52                        | Form                of 8% Senior Subordinated Secured Convertible Note dated September                30,                2004                                                                                                                                  | O                              |
| 10.55                        | Construction                Loan Agreement and related Promissory Note between Hemagen Diagnostics,                Inc. and Reagents Applications, Inc. and Bay National Bank dated                June 24,                2005                                | N                              |
| 10.60                        | Second                modification and amendment to Line of Credit Financing Agreement                between                Hemagen Diagnostics, Inc. and Reagents Applications, Inc. and Bay                National                Bank dated June 24, 2005 | N                              |
| 10.65                        | Lease                Agreement for 330 North Warwick Avenue, Baltimore City, Maryland                between                Hemagen Properties LLC and Hemagen Diagnostics, Inc. dated June 24,                2005                                            | N                              |
| 14.0                         | Code                of Ethics Policy                                                                                                                                                                                                                           | L                              |
| 14.1                         | Insider                Trading Policy                                                                                                                                                                                                                          | L                              |
| 23                           | Consent                of Independent Registered Public Accounting Firm                                                                                                                                                                                        | R                              |
| 31.1                         | Certification                of Chief Executive Officer pursuant to Rule 13a-14(a)                                                                                                                                                                             | Q                              |
| 31.2                         | Certification                of Chief Financial Officer pursuant to Rule 13a-14(a)                                                                                                                                                                             | Q                              |
| 32.1                         | Certification                of Chief Executive Officer pursuant to Rule 13a-14(a)                                                                                                                                                                             | Q                              |
| 32.2                         | Certification                of Chief Financial Officer pursuant to Rule 13a-14(a)                                                                                                                                                                             | Q                              |
|                         |  *Management                compensatory contracts.                                                                                                                                                                                                       |                           |
|                         |                                                                                                                                                                                                                                                           |                           |
| A.                           | Incorporated                by reference to Registration Statement No. 33-52686-B                                                                                                                                                                              |                           |
| B.                           | Incorporated                by reference to Registration Statement on Form 8-K filed on February                10,                1999                                                                                                                        |                           |
| C.                           | Incorporated              by reference to Hemagen’s Form 10-KSB for the fiscal year ended September              30, 2000                                                                                                                                |                           |
| D.                           | Incorporated                by reference to Hemagen’s Form 8-K filed on October 7,                1999                                                                                                                                                   |                           |
| E.                           | Incorporated                by reference to Hemagen’s Form 10-KSB for the fiscal year ended September                30, 2001                                                                                                                            |                           |
| F.                           | Incorporated              by reference to Hemagen's Definitive Proxy Statement filed with the              SEC on              January 29, 2001                                                                                                                |                           |
| G.                           | Incorporated                by reference to Hemagen’s Form S-3 filed on July 21, 2000                                                                                                                                                                    |                           |
| H.                           | Incorporated                by reference to Hemagen’s Form S-8, Registration Statement No. 333-57080,                filed with the SEC on March 15, 2001                                                                                                |                           |
| I.                           | Incorporated                by reference to Hemagen’s 10-QSB for the quarter ended March 31,                2001                                                                                                                                         |                           |
| J.                           | Incorporated                by reference to Hemagen’s Form 8-K filed on March 23, 2001                                                                                                                                                                   |                           |
| K.                           | Incorporated                by reference to Hemagen’s Form 10-KSB for the fiscal year ended September                30, 2002                                                                                                                            |                           |
| L.                           | Incorporated                by reference to Hemagen’s Form 10-KSB for the fiscal year ended September                30, 2003                                                                                                                            |                           |
| M.                           | Incorporated                by reference to Hemagen’s Form 10-KSB for the year ended September 30,                2004                                                                                                                                   |                           |
| N.                           | Incorporated                by reference to Hemagen’s Form 10-QSB for the quarter ended June 30,                2005                                                                                                                                     |                           |
| O.                           | Incorporated                by reference to S-3 filed on May 26, 2005                                                                                                                                                                                          |                           |
| P.                           | Incorporated                by reference to Hemagen’s Form 10-KSB for the year ended September 30,                2005                                                                                                                                   |                           |
| Q.                           | Filed                herewith                                                                                                                                                                                                                                  |                           |
| R.                           | Previously                filed                                                                                                                                                                                                                                |                           |

|                                                                |   | 2006   |    |                    | 2007   |   |
|---------------------------------------------------------------------|--------|--------|---------|-------------------------|--------|--------|
|                                                                |   |   |    |                    |   |   |
| Audit                fees and SAS 100 quarterly review related fees |   | $      | 98,300  |                    |   | $      | 143,600 |   |
|                                                                |   |   |    |                    |   |   |   |   |
| Audit                related fees                                   |   | $      | 0       |                    |   | $      | 0 |   |
|                                                                |   |   |    |                    |   |   |   |   |
| Fees                related to tax services                         |   | $      | 13,075  |                (a) |   | $      | 13,075 |                (a) |
|                                                                |   |   |    |                    |   |   |   |   |
| All                other fees                                       |   | $      | 0       |                    |   | $      | 0 |   |
|                                                                |   |   |    |                    |   |   |   |   |
|                                                                |   | $      | 111,375 |                    |   | $      | 156,675 |   |

| (a) | The                Audit Committee believes the provision of these services is compatible                with maintaining the principal accountant’s independence. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

|                                          | HEMAGEN                DIAGNOSTICS, INC. |                                                 |
|-----------------------------------------------|------------------------------------------|------------------------------------------------------|
|                                          |                                     |                                                 |   |
| Date:                   January 28, 2008 | By:                                      | /s/ William                P. Hales             |   |
|                                          |                                     | William                P. Hales                      |   |
|                                          |                                     | President                and Chief Executive Officer |   |
|                                          |                                     |                                                 |   |

| /s/  William                  P.                  Hales                                                       William                  P. Hales              | President                  and Chief Executive Officer, Director                          | January                  28, 2008                  |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------|----------------------------------------------------|
|                                                                                                                                                                                                                                                                                                                                                            |                                                                                      |                                               |
| /s/                  Alan S.                  Cohen                                                           Alan                  S. Cohen, M.D. | Director                                                                                  | January                  28, 2008                  |
| /s/                  Richard W.                  Edwards                               Richard                  W. Edwards                                                                           | Director                                                                                  | January                  28, 2008                  |
| /s/                  Edward T.                  Lutz                                                          Edward                  T. Lutz           | Director                                                                                  | January                  28, 2008                  |
| /s/ Catherine                  M.                  Davidson                                           Catherine                  M. Davidson                                                                                  | Controller,                  Principal Financial Officer and Principal Accounting Officer | January                  28,                  2008 |